Indegene offers value to life sciences, needs price discovery
The Bengaluru-based company is rolling out a ₹1,842 crore initial public offering comprising a fresh issue of ₹760 crore and an offer of sale of ₹1,082 crore. The IPO represents 17% of the company's post-issue paid-up capital. Proceeds of the issue will be used to trim debt and for capex.
Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.
